Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
United Therapeutics
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Eligible subjects who completed assessments for the final visit of the previous TDE-DU-201 controlled trial and who signed appropriate informed consent were eligible to enroll in this extension study.
If a female of childbearing potential, the subject must have agreed to continue practicing an acceptable method of birth control (i.e., surgical sterilization, approved hormonal contraceptives, barrier methods \[such as a condom or diaphragm\] used with a spermicide, or an intrauterine device).
You may not be if
Have had any change in clinical status that, in the opinion of the Investigator, would pose a safety risk for participation in this extension study;
Have been found to be unable to complete study assessments in the previous controlled trial;
Have prematurely discontinued study drug during the previous study due to clinical worsening or treatment related adverse events.
Clareo Health | Open-Label Study of Oral Treprostinil in Digital Ulcers
